Last reviewed · How we verify
NCT06167954
Safety and Usability of a Robotic Gait Device for Children and Adolescents With Neurological or Neuromuscular Disease in Their Natural Environment
NA trial testing EXPLORER in Cerebral Palsy in 50 participants. Completed in 17 August 2024.
17 August 2024
Quick facts
| Lead sponsor | MarsiBionics |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 4 December 2023 |
| Primary completion | 17 August 2024 |
| Estimated completion | 17 August 2024 |
| Sites | 5 locations across Spain |
Drugs / interventions tested
- EXPLORER
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Acquired Brain Injury — all drugs for Acquired Brain Injury →
- Spinal Muscular Atrophy — all drugs for Spinal Muscular Atrophy →
Sponsor
MarsiBionics
Who can join
Adults 2 to 17, any sex, with Cerebral Palsy or Acquired Brain Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to analyze the usability and safety of the robotic gait device EXPLORER in children with cerebral palsy, acquired brain injury and spinal muscular atrophy. Participants will use the exoskeletons in their home and the community and variables regarding safety and usability will be measured and recorded.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06167954
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of EXPLORER
Trials testing the same drug.
- NCT06765070 — Efficacy and Usability of the EXPLORER Exoskeleton in Children With Neurodevelopmental Disorders in Natural Environments · NA · active not recruiting
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other MarsiBionics trials
Trials by the same sponsor.
- NCT07159360 — Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorder · NA · not yet recruiting
- NCT06894160 — Safety and Usability of the EXPLORER Exoskeleton in Adults With Neuromuscular Diseases · NA · not yet recruiting
- NCT06765070 — Efficacy and Usability of the EXPLORER Exoskeleton in Children With Neurodevelopmental Disorders in Natural Environments · NA · active not recruiting
- NCT05926635 — Efficacy of a Rehabilitation Program With the Pediatric Exoskeleton ATLAS 2030 in Pediatric Patients With Cerebral Palsy · active not recruiting
- NCT05914818 — Proof of Concept of Pediatric and Adolescent EXPLORER V2 Exoskeleton in Children With Neurological and Neuromuscular Dis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06167954 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MarsiBionics
- Last refreshed: 27 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06167954.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing